{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:26:01Z","timestamp":1747171561568,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.thromres.2024.04.019","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T01:50:07Z","timestamp":1713491407000},"page":"85-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peak plasma anti-Xa direct oral anticoagulant levels after gastrointestinal surgeries: A retrospective cohort"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-2740","authenticated-orcid":false,"given":"Menal","family":"Huroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-4427","authenticated-orcid":false,"given":"Rita","family":"Selby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subir","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2705-3615","authenticated-orcid":false,"given":"Jean-Philippe","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-2406","authenticated-orcid":false,"given":"Jameel","family":"Abdulrehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2024.04.019_bb0005","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC subcommittee on control of anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2024.04.019_bb0010","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2146\/ajhp060033","article-title":"Medication and nutrient administration considerations after bariatric surgery","volume":"63","author":"Miller","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"1","key":"10.1016\/j.thromres.2024.04.019_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2024.04.019_bb0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.04.019_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0884533613490740","article-title":"Consequences of gastrointestinal surgery on drug absorption","volume":"28","author":"Titus","year":"2013","journal-title":"Nutr. Clin. Pract."},{"issue":"6","key":"10.1016\/j.thromres.2024.04.019_bb0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/FJC.0000000000001142","article-title":"Direct acting oral anticoagulants following gastrointestinal tract surgery","volume":"78","author":"Hakeam","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"22","key":"10.1016\/j.thromres.2024.04.019_bb0035","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/bloodadvances.2019000369","article-title":"Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy","volume":"3","author":"Al-Samkari","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.thromres.2024.04.019_bb0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11695-021-05814-y","article-title":"Anti-Xa levels in morbidly obese patients using apixaban or rivaroxaban, before and after bariatric surgery","volume":"32","author":"Kok","year":"2022","journal-title":"Obes. Surg."},{"issue":"235","key":"10.1016\/j.thromres.2024.04.019_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2024.01.007","article-title":"Pharmacokinetics of direct oral anticoagulants after bariatric surgery: a retrospective cohort study","volume":"1","author":"Gunka","year":"2024","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2024.04.019_bb0050","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jth.15823","article-title":"Direct oral anticoagulants after bariatric surgery-what is the evidence?","volume":"20","author":"Leong","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2024.04.019_bb0055","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jth.14001","article-title":"Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants","volume":"16","author":"Testa","year":"2018","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T03:34:29Z","timestamp":1716003269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":11,"alternative-id":["S0049384824001324"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.019","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peak plasma anti-Xa direct oral anticoagulant levels after gastrointestinal surgeries: A retrospective cohort","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}